A 65-year-old woman was diagnosed with pulmonary small-cell carcinoma 6 months previously developed sudden-onset consciousness disturbance and left hemiparesis. Her clinical examination revealed a Glasgow Coma Scale (GCS) score of 10 (E3, V3, M4) and severe motor dysfunction (manual muscle test, 2/5). Head computed tomography (CT) showed a 31-mm diameter round, high-density lesion in the right thalamus \[[Figure 1a](#F1){ref-type="fig"}\], with no enhancement contrast agent administration \[[Figure 1b](#F1){ref-type="fig"}\]; no hydrocephalus was present. Her blood pressure was high (190/110 mmHg), but laboratory examination showed no abnormal results, including coagulopathy.

![Radiological examination: (a) computed tomography (CT) showing a high-density area in the right thalamus at admission; (b) CT showing no enhancement of the hematoma following contrast agent administration at admission; (c) CT showing acute hydrocephalus with mild progression of the hematoma 3 h after admission; (d) CT showing significant hematoma progression 5 days after hospitalization; and (e) postoperative CT showing total removal of the right thalamic hemorrhage 6 days after hospitalization](SNI-10-3-g001){#F1}

External ventricular drainage was performed after 3 h because acute hydrocephalus progressed, and her consciousness deteriorated \[[Figure 1c](#F1){ref-type="fig"}\]. CT, performed 5 days after hospitalization, revealed significant hematoma progression in the thalamus with perifocal edema (diameter, 47 mm) \[[Figure 1d](#F1){ref-type="fig"}\], despite good blood pressure control. Total removal of the hematoma in the thalamus was performed via a transcortical, transventricular approach \[[Figure 1e](#F1){ref-type="fig"}\]. Her consciousness recovered immediately after surgery (GCS score 11 \[E4, V3, M4\]). Histopathological examination revealed tiny clusters of small, round cells within the hematoma \[Figure [2a](#F2){ref-type="fig"}, [b](#F2){ref-type="fig"}\]. Immunohistochemically, carcinoma cells tested positive for several neuroendocrine markers, including chromogranin A and synaptophysin \[Figure [2c](#F2){ref-type="fig"} and [d](#F2){ref-type="fig"}\]; therefore, the small-cell carcinoma present in the thalamic hemorrhage was confirmed as lung cancer metastasis.

![Pathologic examination: (a, b) pathologic examination showing some clusters of naked small round cells with hyperchromatic round nuclei in the area of bleeding. Immunohistochemical studies revealing that tumor cells tested positive for (c) synaptophysin A and (d) chromogranin A](SNI-10-3-g002){#F2}

Considering the prognosis of the primary tumor, radiotherapy was not administered at the family\'s request; 30 days after hospitalization, she was transferred to receive palliative medical care. Written informed consent was obtained from the patient and her family.

Brain metastases occur in the gray/white matter region of the cerebral hemisphere. However, metastasis of cancer cells to the thalamus is uncommon (2.2%).\[[@ref1]\] Kondziolka *et al*. demonstrated that 24% (36/147) of metastatic brain tumors develop intratumoral hemorrhages, 25% (9/36) of hemorrhages are macroscopic, and only 2.7% of hemorrhagic metastatic brain tumors are associated with acute neurological symptoms.\[[@ref2]\] These findings indicate that cancer metastasis to the thalamus with secondary hemorrhage and neurological symptoms is rare.

The etiology of intracerebral hemorrhage (ICH) in cancer patients is heterogeneous. The largest clinical series, including 208 cancer patients who developed ICH or subarachnoid hemorrhage, showed that 61% (*n* = 127) of hemorrhages were caused by intratumoral hemorrhage, 46% (*n* = 95) by coagulopathy, 33% (*n* = 69) by multifactorial causes, and 21% (*n* = 44) by intratumoral hemorrhage and coagulopathy.\[[@ref3]\] We failed to detect the tiny metastatic thalamic tumor in our case during the initial radiological examination, despite performing contrast-enhanced CT. The unusual clinical course suggested that a metastatic tumor was responsible for repeated ICH. The standard for diagnosing metastatic brain tumor is contrast MRI,\[[@ref4]\] but it is not usually the first choice for cerebral hemorrhage diagnosis. If ICH is caused by tiny metastatic brain tumors, detecting the cause of ICH during the initial examination can be difficult. Thus, when cerebral hemorrhages occur in a cancer patient, hemorrhage due to a metastatic brain tumor should be considered.
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